OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CMMB

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Chemomab Therapeutics (CMMB) Earnings Date & Reports

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

CMMB is expected to report earnings to rise 1,775.00% to -7 cents per share on November 07

Chemomab Therapeutics CMMB Stock Earnings Reports

Q3'25

Est.

$-0.08

Q2'25

Beat

by $0.10

Q1'25

Est.

$-0.01

Q4'24

Beat

by $0.05

Q3'24

Beat

by $0.07

The last earnings report on August 14 showed earnings per share of 0 cents, beating the estimate of -10 cents. With 126.02K shares outstanding, the current market capitalization sits at 19.31M.

View a ticker or compare two or three

Compare

CMMB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CMMB
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CMMB showed earnings on August 14, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a provider of biopharmaceutical services

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Kiryat Atidim

Phone

+972 773310156

Employees

Web

https://www.chemomab.com